PMID: 11910265Mar 23, 2002Paper

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

Journal of Clinical Psychopharmacology
Joseph ZoharCarol Austin

Abstract

The efficacy of sertraline in the treatment of civilian posttraumatic stress disorder (PTSD) has been established by two large placebo-controlled trials. The purpose of the current pilot study was to obtain preliminary evidence of the efficacy of sertraline in military veterans suffering from PTSD. Outpatient Israeli military veterans with a DSM-III-R diagnosis of PTSD were randomized to 10 weeks of double-blind treatment with sertraline (50-200 mg/day; N = 23, 83% male, mean age = 41 years) or placebo (N = 19, 95% male, mean age = 38 years). Efficacy was evaluated by the Clinician-Administered PTSD Scale (CAPS-2) and by Clinical Global Impression Scale-Severity (CGI-S) and -Improvement (CGI-I) ratings. Consensus responder criteria consisted of a 30% or greater reduction in the CAPS-2 total severity score and a CGI-I rating of "much" or "very much" improved. The baseline CAPS-2 total severity score was 94.3 +/- 12.9 for sertraline patients, which is notably higher than that reported for most studies of civilian PTSD. On an intent-to-treat endpoint analysis, sertraline showed a numeric but not statistically significant advantage compared with placebo on the CAPS-2 total severity and symptom cluster scores. In the study completer...Continue Reading

References

Jun 1, 1991·The Journal of Nervous and Mental Disease·T R KostenE L Giller
Mar 1, 1990·Archives of General Psychiatry·J DavidsonJ O Cavenar
May 1, 1988·Psychiatry Research·M ShestatzkyB Lerer
Dec 1, 1995·Archives of General Psychiatry·R C KesslerC B Nelson
Apr 29, 1999·International Clinical Psychopharmacology·R HidalgoJ Davidson
Jan 6, 2000·The British Journal of Psychiatry : the Journal of Mental Science·K M ConnorJ R Davidson
Jan 8, 2000·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·J A Boscarino, J Chang
Apr 19, 2000·JAMA : the Journal of the American Medical Association·K BradyG M Farfel
May 19, 2000·The Journal of Clinical Psychiatry·S ZisookJ C Gillin

❮ Previous
Next ❯

Citations

Feb 22, 2012·Social Psychiatry and Psychiatric Epidemiology·Ilan Harpaz-RotemRobert A Rosenheck
Oct 24, 2002·Journal of Psychiatric Research·Ronald C Albucher, Israel Liberzon
Jun 24, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael A MatarJoseph Zohar
Nov 3, 2009·The Clinical Neuropsychologist·Thomas W McAllister
Dec 29, 2010·Journal of Child and Adolescent Psychopharmacology·Adelaide S RobbDouglas G Vanderburg
Nov 2, 2011·Journal of Child and Adolescent Psychopharmacology·Frederick J StoddardRobert L Sheridan
Dec 1, 2009·Journal of Addiction Medicine·Kathleen T BradyHugh Myrick
Mar 1, 2009·International Clinical Psychopharmacology·David V Sheehan, Kunitoshi Kamijima
Dec 18, 2004·Forschende Komplementärmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine·L Sher
Jan 15, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Huang NieQingrong Tan
Aug 16, 2005·Current Psychiatry Reports·Damiaan Denys, Femke de Geus
Apr 28, 2005·Expert Review of Neurotherapeutics·Mark B Hamner, Sophie Robert
Apr 28, 2005·Expert Review of Neurotherapeutics·Martin A KatzmanJoanna C McBride
Jun 15, 2007·Expert Review of Neurotherapeutics·Chi-Un PaeAshwin A Patkar
Jan 1, 2009·Expert Review of Clinical Pharmacology·Christopher P AldermanAnita C Marwood
Aug 19, 2007·Expert Opinion on Pharmacotherapy·Wei Zhang, Jonathan Rt Davidson
May 21, 2009·Expert Opinion on Emerging Drugs·Dewleen G BakerVictoria B Risbrough
Feb 9, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ralph J KoekAndrew Leuchter
Apr 2, 2013·Journal of Psychiatric Research·Thomas D GeraciotiNosakhare N Ekhator
Sep 18, 2012·Journal of Psychiatric Research·Alline Cristina CamposFrancisco Silveira Guimarães
Jul 9, 2011·Neuropharmacology·Thomas Steckler, Victoria Risbrough
Jun 1, 2009·Psychiatric Annals·Gregory M Sullivan, Yuval Neria
Jan 15, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·William BergerIvan Figueira
Oct 2, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Somaia Mohamed, Robert Rosenheck
Jan 15, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Li-Ming ZhangYun-Feng Li
Nov 30, 2005·International Journal of Geriatric Psychiatry·Gina P OwensSomaia Mohamed
Aug 8, 2006·Annals of the New York Academy of Sciences·Hagit CohenJoseph Zohar
Oct 20, 2010·Annals of the New York Academy of Sciences·Rachel YehudaMichelle Pelcovitz
Feb 11, 2011·Human Psychopharmacology·Mujeeb U ShadCarol S North
Aug 19, 2014·Human Psychopharmacology·Hee Ryung WangWon-Myong Bahk
Dec 17, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ferenc Martenyi, Victoria Soldatenkova
Aug 9, 2011·Expert Opinion on Pharmacotherapy·Laura C PratchettRachel Yehuda
Oct 22, 2002·Expert Opinion on Pharmacotherapy·Ann C Schwartz, Barbara O Rothbaum
Jan 5, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Sanjay J MathewDennis S Charney
Mar 10, 2015·Current Psychiatry Reports·Nancy C Bernardy, Matthew J Friedman
Jul 30, 2011·The International Journal of Neuropsychopharmacology·Jonathan C Ipser, Dan J Stein
Jul 5, 2016·Frontiers in Immunology·Zhewu Wang, M Rita I Young
Jul 17, 2010·Brain Stimulation·Mushtaq A MargoobChittaranjan Andrade
Jul 16, 2016·Journal of Natural Medicines·Bombi LeeDae-Hyun Hahm
Nov 5, 2016·Neuroscience·Catherine LauJacqueline Blundell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.